These two mothers may have experienced an already prolonged period of anemia because the treatment was given late in the second trimester and the time to benefit from increased Hb levels (+2.9 and +2.8 g/dL) may have been too short. The gene discussed is GSTM1; the disease is anemia (phenotype).